• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.62% Nasdaq Up 0.35%

    More On GLPG.BR

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Galapagos NV (GLPG.BR)

    -Brussels
    33.30 Down 1.45(4.16%) 3:25AM EST
    Prev Close:34.74
    Open:34.40
    Bid:33.29 x 1000
    Ask:33.49 x 5400
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:33.22 - 34.40
    52wk Range:15.99 - 34.40
    Volume:25,300
    Avg Vol (3m):0
    Market Cap:992.14M
    P/E (ttm):30.22
    EPS (ttm):1.10
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in EUR.

    Headlines

    » More Headlines for GLPG.BR

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-11) :N/A
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Galapagos NV, a clinical stage biotech company, develops and commercializes novel medicines in Belgium, Croatia, France, and the Netherlands. Its products include GLPG0634, an orally-available selective inhibitor of Janus kinase 1, which is in Pha... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback